AKT1 and breast cancer: The inhibition of hyaluronan synthesis by 4-methylumbelliferone is due to a suppressed phosphorylation of AKT, and treatment of breast cancer cells with 4-methylumbelliferone leads to smaller osteolytic lesions in a mouse model [93].